Ultragenyx Pharmaceutical Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.13M2.61M51.49M103.71M271.03M351.41M363.33M434.25M560.23M
Cost of Revenue 0.00M1.15M9.01M6.13M16.01M28.32M45.21M76.73M
Gross Profit 0.13M2.61M50.35M94.71M264.90M335.40M335.01M389.04M483.50M
Operating items
Research & Development 45.97M114.74M183.20M231.64M294.00M357.36M412.08M497.15M705.79M648.45M697.87M
Selling, General & Administrative 10.81M33.00M64.94M99.91M127.72M161.52M182.93M219.98M278.14M309.80M321.61M
Other Operating Expenses 306.60M341.70M170.32M9.01M6.13M16.01M28.32M45.21M76.73M
Operating Expenses 56.78M147.74M248.14M331.55M422.87M527.89M601.15M733.14M1012.25M1003.46M1096.20M
Operating Income -56.78M-147.74M-248.01M-328.94M-371.37M-424.17M-330.12M-381.74M-648.92M-569.21M-535.97M
EBIT -56.78M-147.74M-248.01M-328.94M-371.37M-424.17M-330.12M-381.74M-648.92M-569.21M-535.97M
Non-operating items
Interest & Investment Income 0.61M2.32M3.79M4.07M9.54M13.24M7.04M1.93M11.07M26.69M36.51M
Other Non Operating Income -3.63M-0.20M-1.62M6.53M-5.59M-0.79M0.61M-1.69M-1.57M-0.34M-3.96M
Non Operating Income -3.63M-0.20M-1.62M6.53M-5.59M-0.79M0.61M-1.69M-1.57M-0.34M-3.96M
Net income details
EBT -59.80M-145.62M-245.84M-318.34M-205.44M-399.71M-189.45M-455.31M-703.41M-608.46M-567.59M
Tax Provisions 0.04M-16.20M0.51M3.28M1.21M1.04M7.34M-1.82M2.97M
Profit After Tax -59.80M-145.62M-245.87M-302.14M-197.61M-402.73M-186.57M-454.02M-707.42M-606.64M-569.18M
Equity Income 13.41M170.40M-42.06M-19.30M0.40M-1.11M
Income from Continuing Operations -59.80M-145.62M-245.87M-302.14M-205.95M-402.99M-190.66M-456.36M-710.75M-606.64M-570.55M
Consolidated Net Income -59.80M-145.62M-245.87M-302.14M-205.95M-402.99M-190.66M-456.36M-710.75M-606.64M-570.55M
Income towards Parent Company -59.80M-145.62M-245.87M-302.14M-205.95M-402.99M-190.66M-456.36M-710.75M-606.64M-570.55M
Net Income towards Common Stockholders -59.80M-145.62M-245.87M-302.14M-205.95M-402.99M-190.66M-456.36M-710.75M-606.64M-570.55M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 28.14M31.90M38.83M40.86M42.59M50.58M57.77M61.04M68.16M70.11M82.11M92.34M
Shares Outstanding (Diluted Average) 60.85M67.80M69.91M73.54M90.54M
EBITDA -56.78M-147.74M-248.01M-328.94M-371.37M-424.17M-330.12M-381.74M-648.92M-569.21M-535.97M
Tax Rate 5.09%0.30%